1
Pharmacotherapy for Cardiovascular Disorders
Walden University
NURS 6521: Advanced Pharmacology
Date
2
Introduction
With the turn of the century, cardiovascular diseases have become the leading cause of mortality
in the world. Globally, cardiovascular diseases are the leading cause of death. In an estimated 17
million people are killed by cardiovascular disease yearly, accounting for 30% of global deaths.
7.2 million of these deaths have been due to heart attacks and 5.7 million have been caused by
stroke. Some 80% of such deaths occurred in countries with lower and middle incomes. When
current trends continue, an estimated 23.6 million people (mostly from heart attacks and strokes)
will die from cardiovascular disease by 2030. Cardiovascular diseases affect a large number of
middle-aged people, which very often drastically reduce the savings and investments of the
individuals and families affected. Lost profits and out - of-pocket health care payments
undermine community and nation socioeconomic development.
Among young adult in the high-income countries the prevalence of predisposing factors to
cardiovascular disease has steadily increased. Weak cardiovascular health habits have shown
higher rates of middle-aged adults with reported hyper, critical hypertension and coronary
disease (Pool et al. 2019).
A4transient4ischaemic4attack4is4just4like4a4stroke,4except4that4symptoms4lasts4a4short4period4of4tim
